Mutations in the NPC1 gene can influence drug metabolism by altering the cellular distribution of lipids, which may affect the pharmacokinetics of lipid-soluble drugs. This can lead to unexpected drug interactions and toxicity, making it crucial for toxicologists to consider NPC1 gene status when assessing drug safety and efficacy.
